Diaminopyrazolo[1,5-a]pyrimidine-6-carbonitrile compounds as adenosine 2A receptor and adenosine 2B receptor antagonists

JP7885136B2Inactive Publication Date: 2026-07-06BUGWORKS RESEARCH INC
View PDF 3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
BUGWORKS RESEARCH INC
Filing Date
2022-01-07
Publication Date
2026-07-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Benefits of technology

【1445】 本発明の利点: 本開示は、式Iの複素環式化合物の新規クラス、それの薬学的に許容される塩、錯体、水和物、溶媒和物、互変異性体、多形体、立体異性体、ラセミ体、その薬学的に活性な誘導体を提供する。本開示は、医薬としての使用のための式Iの複素環式化合物の新規クラスを提供する。式Iの化合物は、アデノシン受容体、特にアデノシンA2aR及びA2bR受容体のためのアンタゴニストとして作用する。式Iの化合物は、アデノシン受容体によって媒介される増殖性障害、疾患、状態、がん又は免疫関連疾患の処置において広く使用することができる。

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007885136000442
    Figure 0007885136000442
  • Figure 0007885136000443
    Figure 0007885136000443
  • Figure 0007885136000001
    Figure 0007885136000001
Patent Text Reader

Abstract

The present disclosure provides a compound of formula I or its pharma- ceutically acceptable salts, complexes, hydrates, solvates, tautomers, polymorphs, stereoisomers, racemates, and pharma- ceutically active derivatives thereof. The compound of formula I acts as an antagonist to adenosine receptors. The present disclosure also provides processes for the preparation of the compound of formula I and its pharmaceutical compositions. TIFF2024507022000440.tif50163
Need to check novelty before this filing date? Find Prior Art

Claims

1. Equation I 【Chemistry 1】 Compounds thereof, or pharmaceutically acceptable salts, hydrates, solvates, tautomers, stereoisomers, and racemates thereof. (In the formula, A is, 【Chemistry 2】 (* indicates an attachment point) Selected from, In the equation, Q is N, R 2 is hydrogen or C 1~6 It is alkyl; R 3 is hydrogen or C 1~6 It is alkyl; R 4 and R 5 are each independently selected from halogen, C 1~6 alkyl, C 3~6 cycloalkyl or C 1~6 haloalkyl, where C 1~6 alkyl is optionally substituted with C 3~6 cycloalkyl; R 6 is hydrogen, C 1~6 Alkyl, C 1~6 Haloalkyl, C3-6 cycloalkyl, C 1~6 Alkoxy, C 1~6 Alkylhydroxy, C 1~6 Aminoalkyl, -Y-CO-NH-R 13 , -YZ or C 1~10 Selected from heterocyclines, where C 1~6 Alkyl, C 1~6 Alkoxy, C 3~6 Cycloalkyl, C 1~6 Haloalkyl, C 1~6 Aminoalkyl, C 1~6 Alkylhydroxy or C 1~10 Heterocyclines are halogens, hydroxyls, amines, and C 1~6 Alkoxy, C 3~6 Cycloalkyl, C 1~6 Alkylhydroxy, C 1~6 Aminoalkyl or C 1~10 It is optionally substituted with one or more groups selected from heterocyclines, where C 3~6 Cycloalkyl, or C 1~6 Aminoalkyls are halogens, hydroxyls, and C 1~6 Alkylhydroxy, -C(O)C 1~6 Alkyl, -C(O)NH 2 or -C(O)-C 1~6 It is further optionally substituted with one or more groups independently selected from alkylhydroxy; Y is C 1~6 Alkyl or C 3~6 It is a cycloalkyl; Z is -SOCH 3 ,-SCH 3 CH 2 -NH-(C 1~6 Alkyl)-SOCH 3 or -NHCO(C 1~6 Selected from alkyl; R 13 is hydrogen, C 1~6 Alkyl or C 3~6 Selected from cycloalkyl groups; R 7 , R 8 , and R9 are hydrogen, halogen, cyano, C 1~6 Alkyl or C 1~6 Selected independently of alkoxy; n is either 0 or 1.

2. A compound according to claim 1, or a pharmaceutically acceptable salt, hydrate, solvate, tautomer, stereoisomer, or racemate thereof, selected from the group consisting of the following:

1. 7-amino-2,3-dimethyl-5-{[1-(6-methylpyridine-2-yl)ethyl]amino}pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 2. 7-amino-2,3-dimethyl-5-{[(1S)-1-(6-methylpyridine-2-yl)ethyl]amino}pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 3. (R)-7-amino-3-ethyl-2-methyl-5-((1-(pyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 4. (S)-7-amino-3-ethyl-2-methyl-5-((1-(pyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 5. (S)-7-amino-3-ethyl-2-methyl-5-((1-(6-methylpyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 6. 7-amino-2,3-dimethyl-5-{[(6-methylpyridine-2-yl)methyl]amino}pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 7. 7-amino-5-{[(6-ethylpyridine-2-yl)methyl]amino}-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 8. 7-amino-2,3-dimethyl-5-{methyl[(6-methylpyridine-2-yl)methyl]amino}pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 9. 7-amino-5-({[6-(2-hydroxypropan-2-yl)pyridine-2-yl]methyl}amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 10. 7-amino-2,3-dimethyl-5-((2-(5-methylpyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 11. 7-amino-5-((2-(5-fluoropyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 12. 7-amino-5-((2-(6-methoxypyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 13. 7-amino-5-((2-(6-methylpyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 14. Chiral 7-amino-2,3-dimethyl-5-{[1-(6-methylpyridine-2-yl)propane-2-yl]amino}pyrazolo[1,5-a]pyrimidine-6-carbonitrile (isomer 1) 【Transformation 3】 (In the formula, 'a' indicates that the absolute configuration is unknown); 15. Chiral 7-amino-2,3-dimethyl-5-{[1-(6-methylpyridine-2-yl)propane-2-yl]amino}pyrazolo[1,5-a]pyrimidine-6-carbonitrile (isomer 2) 【Chemistry 4】 (In the formula, 'a' indicates that the absolute configuration is unknown); 16. 7-amino-5-({2-[6-(2-hydroxypropan-2-yl)pyridine-2-yl]ethyl}amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 17. 7-amino-3-ethyl-2-methyl-5-((2-(6-methylpyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 18. 7-amino-3-ethyl-2-methyl-5-((2-(5-methylpyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 19. 7-amino-3-ethyl-5-((2-(5-methoxypyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 20. 7-amino-3-ethyl-5-((2-(6-methoxypyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 21. 7-amino-3-ethyl-5-((2-(5-fluoropyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 22. Chiral 7-amino-3-ethyl-2-methyl-5-((1-(pyridine-2-yl)propan-2-yl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile (isomer 1) 【Transformation 5】 (In the formula, 'a' indicates that the absolute configuration is unknown); 23. Chiral 7-amino-3-ethyl-2-methyl-5-((1-(pyridine-2-yl)propan-2-yl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile (isomer 2) 【Transformation 6】 (In the formula, 'a' indicates that the absolute configuration is unknown.) 24. 7-amino-3-ethyl-2-methyl-5-((1-(6-methylpyridine-2-yl)propan-2-yl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 25. 7-amino-3-ethyl-5-({2-[6-(2-hydroxypropan-2-yl)pyridine-2-yl]ethyl}amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 26. 7-amino-3-(cyclopropylmethyl)-2-methyl-5-((2-(6-methylpyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 27. 7-amino-3-(isopropylmethyl)-2-methyl-5-((2-(6-methylpyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 28. 7-amino-3-(isopropyl)-2-methyl-5-((2-(6-methylpyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 29. 7-amino-5-{[2-(1-ethyl-1H-pyrazole-3-yl)ethyl]amino}-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 30. 7-amino-3-ethyl-5-{[2-(1-ethyl-1H-pyrazole-3-yl)ethyl]amino}-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 31. 7-amino-5-({2-[1-(1-hydroxy-2-methylpropan-2-yl)-1H-pyrazole-3-yl]ethyl}amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 32. 7-amino-3-ethyl-5-((2-(1-(1-hydroxy-2-methylpropan-2-yl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 33. 7-amino-3-chloro-5-((2-(6-(hydroxymethyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 34. 7-amino-3-chloro-5-((2-(6-(1-(hydroxymethyl)cyclopropyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 35. 7-amino-3-chloro-5-((2-(1-(2-hydroxyethyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 36. 7-amino-3-chloro-5-((2-(1-(1-hydroxy-2-methylpropan-2-yl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 37. 7-amino-3-chloro-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 38. 7-amino-3-chloro-5-((2-(6-(2-(hydroxymethyl)cyclopropyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 39. 7-amino-3-ethyl-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 40. Amino-5-((2-(6-ethylpyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 41. 7-amino-5-((2-(3-fluoro-6-methylpyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 42. 7-amino-2-ethyl-3-methyl-5-((2-(6-methylpyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 43. 7-amino-2-ethyl-5-((2-(6-(2-hydroxypropan-2-yl)pyridine-2-yl)ethyl)amino)-3-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 44. 7-amino-5-((2-(6-(hydroxymethyl)pyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 45. 7-amino-3-ethyl-5-((2-(6-(hydroxymethyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 46. ​​7-amino-3-(cyclopropylmethyl)-5-((2-(6-(hydroxymethyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 47. 7-amino-2-cyclopropyl-5-((2-(6-(2-hydroxypropan-2-yl)pyridine-2-yl)ethyl)amino)-3-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 48. 7-amino-2-(difluoromethyl)-3-ethyl-5-((2-(1-(1-hydroxy-2-methylpropan-2-yl)-1H-pyrazole-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 49. 7-amino-5-((2-(6-(1-(hydroxymethyl)cyclopropyl)pyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 50. 7-amino-3-ethyl-5-((2-(6-(1-(hydroxymethyl)cyclopropyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 51. 7-amino-5-((2-(6-(2-(hydroxymethyl)cyclopropyl)pyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 52. 7-amino-3-ethyl-5-((2-(6-(1-hydroxy-2-methylpropan-2-yl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 53. 7-amino-5-((2-(6-(1-hydroxy-2-methylpropane-2-yl)pyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 54. 7-amino-3-ethyl-5-((2-(1-(2-hydroxyethyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 55. 7-amino-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 56. 7-amino-2-(difluoromethyl)-3-ethyl-5-((2-(6-(hydroxymethyl)pyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 57. 7-amino-5-(((1-(1-hydroxy-2-methylpropan-2-yl)-1H-pyrazole-3-yl)methyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 58. 7-Amino-2-(difluoromethyl)-3-ethyl-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 59. 7-Amino-2-(difluoromethyl)-3-ethyl-5-((2-(6-(2-(hydroxymethyl)cyclopropyl)pyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitriel; 60. 7-amino-3-ethyl-5-((2-(6-(2-(hydroxymethyl)cyclopropyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 61. 7-amino-3-chloro-5-((2-(4-(1-(hydroxymethyl)cyclopropyl)thiazole-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 62. 7-amino-3-ethyl-5-((2-(4-fluoro-1-(1-hydroxy-2-methylpropan-2-yl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 63. 7-amino-3-ethyl-5-((2-(1-((1-(hydroxymethyl)cyclopropyl)methyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 64. 7-amino-3-chloro-5-((2-(6-(1,1-difluoro-2-hydroxyethyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 65. 7-amino-3-chloro-5-((2-(6-(1-hydroxy-2-methylpropane-2-yl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 66. 7-amino-3-ethyl-5-((2-(4-(1-(hydroxymethyl)cyclopropyl)thiazole-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 67. 7-amino-3-chloro-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 68. 7-amino-5-((2-(1-(1-(aminomethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-3-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 69. 7-amino-3-bromo-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 70. 7-amino-3-chloro-5-((2-(1-ethyl-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 71. 7-amino-3-ethyl-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 72. 7-amino-3-bromo-5-((2-(6-(hydroxymethyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 73. 7-amino-3-chloro-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-4-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 74. 7-amino-3-(cyclopropylmethyl)-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 75. 7-amino-3-chloro-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-5-methyl-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 76. 7-amino-3-ethyl-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-5-methyl-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 77. N-((1-(3-(2-((7-amino-3-chloro-6-cyano-2-methylpyrazolo[1,5-a]pyrimidine-5-yl)amino)ethyl)-1H-pyrazole-1-yl)cyclopropyl)methyl)acetamide; 78. (+)-7-amino-3-ethyl-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 79. (-)-7-amino-3-ethyl-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 80. 7-amino-3-ethyl-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-5-methyl-1H-pyrazole-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 81. 7-amino-3-ethyl-5-((2-(1-(1-hydroxypropan-2-yl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 82. (+-)-7-amino-3-chloro-5-((2-(1-((3-hydroxycyclobutyl)methyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 83. (+)-7-amino-3-chloro-5-((2-(1-((3-hydroxycyclobutyl)methyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 84. (-)-7-amino-3-chloro-5-((2-(1-((3-hydroxycyclobutyl)methyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile(83b); 85. 7-amino-3-ethyl-5-((2-(1-((3-hydroxycyclobutyl)methyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 86. 7-amino-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-5-methyl-1H-pyrazole-3-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 87. 7-amino-3-chloro-2-methyl-5-((2-(1-methyl-2-oxo-1,2-dihydropyridine3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 88. 7-amino-3-ethyl-2-methyl-5-((2-(1-methyl-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitriel; 89. 7-amino-3-bromo-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-5-methyl-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 90. 7-amino-3-chloro-5-((2-(6-(((2-hydroxyethyl)amino)methyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 91. 7-amino-3-ethyl-5-((2-(5-fluoro-6-(hydroxymethyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 92. 7-amino-3-chloro-5-((2-(1-(2-methoxyethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 93. 7-amino-3-chloro-5-((2-(1-(2-hydroxyethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 94. 7-amino-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methyl-3-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 95. 7-amino-5-((2-(1-(2-(aminomethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-3-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 96. 7-amino-3-ethyl-5-((2-(6-(((2-methoxyethyl)amino)methyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 97. 7-amino-3-ethyl-5-((2-(6-(((2-hydroxyethyl)amino)methyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 98. 7-amino-3-chloro-5-((2-(1-(1-(((2-hydroxyethyl)amino)methyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 99. N-((1-(3-(2-((7-amino-3-chloro-6-cyano-2-methylpyrazolo[1,5-a]pyrimidine-5-yl)amino)ethyl)-1H-pyrazole-1-yl)cyclopropyl)methyl)-3-hydroxypropanamide; 100. 7-amino-3-ethyl-5-((2-(6-(1-hydroxyethyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 101. 7-amino-3-cyclopropyl-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 102. 7-amino-2-(difluoromethyl)-3-ethyl-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 103. (+-)-7-amino-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 104. (+)-7-amino-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile(104a); 104b. (-)-7-amino-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile(104b); 105. 7-amino-5-((2-(6-(((2-hydroxyethyl)amino)methyl)pyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 106. 7-amino-3-ethyl-5-((2-(1-(1-(((2-hydroxyethyl)amino)methyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 107. 7-amino-3-ethyl-5-((2-(1-(2-methoxyethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 108. 7-amino-3-ethyl-5-((2-(1-(2-hydroxyethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 109. 7-amino-5-((2-(1-(2-(aminomethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-3-ethyl-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 110. 7-amino-3-ethyl-5-((2-(1-(3-hydroxypropyl)-1H-pyrazole-5-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 111. 7-amino-3-ethyl-5-((2-(1-(3-hydroxypropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 112. 7-amino-3-chloro-5-((2-(1-(1-(2-hydroxyethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 113. 7-amino-3-ethyl-5-((2-(1-(3-hydroxypropyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 114. 7-amino-3-chloro-5-((2-(1-(2-(hydroxymethyl)cyclopentyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 115. 7-amino-3-ethyl-5-((2-(1-(2-(hydroxymethyl)cyclopentyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 116. 7-amino-3-(cyclopropylmethyl)-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 117. 7-amino-3-chloro-5-((2-(1-(2-(((2-hydroxyethyl)amino)methyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 118. 7-amino-5-((2-(1-(2-(aminomethyl)cyclopentyl)-1H-pyrazole-3-yl)ethyl)amino)-3-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 119. 7-amino-3-chloro-2-methyl-5-((2-(6-methylpyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 120. 7-amino-3-chloro-5-((2-(6-ethylpyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 121. (+-)-7-amino-3-ethyl-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 122a. (+)-7-amino-3-ethyl-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile(122a); 122b. (-)-7-amino-3-ethyl-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 123. 7-amino-3-ethyl-5-((2-(1-(3-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 124. 7-amino-3-ethyl-5-((2-(1-(1-(2-hydroxyethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 125. 7-amino-5-((2-(1-(2-aminoethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-3-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 126. 7-amino-5-((2-(1-(2-aminoethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-3-ethyl-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 127. 7-amino-3-chloro-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 128. 7-amino-3-ethyl-5-((2-(1-((3-hydroxycyclobutyl)methyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; 129. 7-amino-5-((2-(1-(3-aminopropyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-3-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 130. 7-amino-3-bromo-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 131. 7-Amino-2-(difluoromethyl)-3-ethyl-5-((2-(1-(2-hydroxyethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 132. (+-)-7-amino-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-1H-pyrazole-3-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 133a. (+)-7-amino-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-1H-pyrazole-3-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile(133a); 133b. (-)-7-amino-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-1H-pyrazole-3-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 134. 2-(((2-(3-(2-((7-amino-6-cyano-3-ethyl-2-methylpyrazolo[1,5-a]pyrimidine-5-yl)amino)ethyl)-1H-pyrazole-1-yl)cyclobutyl)methyl)amino)acetamide; 135. 7-amino-3-ethyl-2-methyl-5-((2-(6-(2,2,2-trifluoro-1-hydroxyethyl)pyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6 ​​carbonitrine; 136. 7-amino-5-((2-(1-(3-aminopropyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-3-ethyl-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 137. 7-amino-3-(cyclobutylmethyl)-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 138. 7-amino-5-((2-(1-(3-hydroxypropyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 139. 7-amino-3-ethyl-5-((2-(6-(2-hydroxyethyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 140. 7-amino-2,3-dimethyl-5-((2-(6-methylpyrazine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 141. 7-amino-5-((2-(1-(3-aminopropyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 142. 7-amino-3-ethyl-2-methyl-5-((2-(1-(2-(methylthio)ethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 143. (+-)7-amino-3-ethyl-2-methyl-5-((2-(1-(2-(methylsulfinyl)ethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 144a. (+)7-amino-3-ethyl-2-methyl-5-((2-(1-(2-(methylsulfinyl)ethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitriel; 144b. (-)7-amino-3-ethyl-2-methyl-5-((2-(1-(2-(methylsulfinyl)ethyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 145. N-(3-(3-(2-((7-amino-6-cyano-3-ethyl-2-methylpyrazolo[1,5-a]pyrimidine-5-yl)amino)ethyl)-2-oxopyridine-1(2H)-yl)propyl)acetamide; 146. 7-amino-5-((2-(1-(1-(aminomethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-3-ethyl-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 147. N-((1-(3-(2-((7-amino-6-cyano-3-ethyl-2-methylpyrazolo[1,5-a]pyrimidine-5-yl)amino)ethyl)-1H-pyrazole-1-yl)cyclopropyl)methyl)acetamide; 148. 7-amino-5-((2-(1-(1-(2-aminoethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-3-ethyl-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 149. N-(2-(1-(3-(2-((7-amino-6-cyano-3-ethyl-2-methylpyrazolo[1,5-a]pyrimidine-5-yl)amino)ethyl)-1H-pyrazole-1-yl)cyclopropyl)ethyl)acetamide; 150. 7-amino-3-ethyl-5-((2-(6-(2-hydroxyethoxy)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 151. 7-Amino-5-((2-(1-(1-(2-aminoethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-3-chloro-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 152. 7-amino-5-((2-(6-(2-hydroxyethyl)pyridine-2-yl)ethyl)amino)-2,3-dimethylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 153. 7-amino-3-ethyl-2-methyl-5-((2-(1-(3-(methylthio)propyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 154a. (-)-7-amino-3-ethyl-2-methyl-5-((2-(1-(3-(methylsulfinyl)propyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile(154a); 154b. (+)-7-amino-3-ethyl-2-methyl-5-((2-(1-(3-(methylsulfinyl)propyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 155. 7-amino-3-ethyl-5-((2-(6-(3-hydroxypropyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 156. 7-amino-5-((2-(1-(3-hydroxypropyl)-2-oxo-1,2-dihydropyridine-3-yl)ethyl)amino)-2-methyl-3-propylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 157. 7-amino-5-((2-(6-(hydroxymethyl)pyridine-2-yl)ethyl)amino)-2-methyl-3-propylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 158. 7-amino-5-((2-(1-(1-(hydroxymethyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methyl-3-propylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 159a. (+)-7-amino-3-ethyl-5-((2-(6-(1-hydroxyethyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile(159a); 159b. (-)-7-amino-3-ethyl-5-((2-(6-(1-hydroxyethyl)pyridine-2-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 160a. (+)7-amino-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-1H-pyrazole-3-yl)ethyl)amino)-2-methyl-3-propylpyrazolo[1,5-a]pyrimidine-6-carbonitrile (160a); 160b. (-)7-amino-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-1H-pyrazole-3-yl)ethyl)amino)-2-methyl-3-propylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 161. 7-amino-3-ethyl-2-methyl-5-((2-(1-(3-(methylthio)propyl)-1H-pyrazole-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 162a. (-)-7-amino-3-ethyl-2-methyl-5-((2-(1-(3-(methylsulfinyl)propyl)-1H-pyrazole-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile(162a); 162b. (+)-7-amino-3-ethyl-2-methyl-5-((2-(1-(3-(methylsulfinyl)propyl)-1H-pyrazole-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 163a. ​​(-)-7-amino-3-ethyl-2-methyl-5-((2-(1-(1-(((2-(methylsulfinyl)ethyl)amino)methyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile (163a); 163b. (+)-7-amino-3-ethyl-2-methyl-5-((2-(1-(1-(((2-(methylsulfinyl)ethyl)amino)methyl)cyclopropyl)-1H-pyrazole-3-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitride; 164. 7-amino-2-methyl-5-((2-(6-methylpyridine-2-yl)ethyl)amino)-3-propylpyrazolo[1,5-a]pyrimidine-6-carbonitrile; 165a. (+)-7-amino-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methyl-3-propylpyrazolo[1,5-a]pyrimidine-6-carbonitrile(165a); 165b. (-)-7-amino-5-((2-(1-(2-(hydroxymethyl)cyclobutyl)-1H-pyrazole-3-yl)ethyl)amino)-2-methyl-3-propylpyrazolo[1,5-a]pyrimidine-6-carbonitride; 166. (R)-7-amino-3-ethyl-2-methyl-5-((2-(6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridine-2-yl)ethyl)amino)pyrazolo[1,5-a]pyrimidine-6-carbonitrile; 167. (-)-7-amino-3-ethyl-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-5-methyl-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitriel; and 168. (+)-7-amino-3-ethyl-5-((2-(1-(4-(hydroxymethyl)tetrahydrofuran-3-yl)-5-methyl-1H-pyrazole-3-yl)ethyl)amino)-2-methylpyrazolo[1,5-a]pyrimidine-6-carbonitride.

3. A pharmaceutical product comprising the compound described in claim 1 or 2, or a pharmaceutically acceptable salt, hydrate, solvate, tautomer, stereoisomer, or racemate thereof.

4. Adenosine 2a receptor (A 2a R) or adenosine 2b receptor (A 2b R) or adenosine 2a receptor (A 2a R) and adenosine 2b receptor (A 2b A compound according to claim 1 or 2, or a pharmaceutically acceptable salt, hydrate, solvate, tautomer, stereoisomer, or racemate thereof, which acts as an antagonist to the combination of R).

5. A compound according to claim 1 or 2, or a pharmaceutically acceptable salt, hydrate, solvate, tautomer, stereoisomer, or racemic mixture thereof, comprising an adenosine 2a receptor (A 2a R) or adenosine 2b receptor (A 2b R) or A 2a R and A 2b A pharmaceutical composition for use in the treatment of a disease, disorder, or condition selected from cancer, Parkinson's disease, asthma, diabetes, and immune response-related disorders, which is at least partially mediated by a combination of R.

6. A method for preparing a compound of formula I according to claim 1 or 2, or a pharmaceutically acceptable salt, hydrate, solvate, tautomer, stereoisomer, or racemate thereof, comprising the step of reacting formulas (A) and (B) in the presence of a base and a solvent to obtain a compound of formula I. 【Transformation 7】 (In the formula, R is C 1~6 Alkyl, C 3~6 Cycloalkyl, C 5~10 Ariel, C 2~10 Heteroaryl or C 1~10 (Selected from heterocyclines).

7. The method according to claim 6, wherein the base is selected from triethylamine, diisopropylethylamine, pyridine, sodium carbonate, potassium carbonate, sodium hydroxide, potassium tertoxide, sodium hydride, lithium bis(trimethylsilyl)amide (LiHMDS), N-diisopropylethylamine, or a combination thereof.

8. The method according to claim 6, wherein the solvent is selected from isopropanol, methanol, n-butanol, dichloromethane, tetrahydrofuran, dimethylformamide, n-methylpyrrolidone, dimethyl sulfoxide, water, dioxane, acetonitrile, or a combination thereof.

9. A pharmaceutical composition comprising a compound of formula I as described in claim 1 or 2 and one or more additional therapeutic agents.

10. One or more additional therapeutic agents are chemotherapeutic agents or immune checkpoint inhibitors; chemotherapeutic agents are selected from phosphoinositide 3-kinase inhibitors (PI3K) inhibitors, tyrosine kinase inhibitors, Stat-3 (T3) inhibitor signal transducers and activators, topoisomerase inhibitors, protein kinase B (AKT) inhibitors, c-Jun N-terminal kinase (JNK1 / K2) inhibitors, hypoxia-inducing factor 1 alpha (HIF-1a) inhibitors, extracellular signal-regulated kinase (ERK) inhibitors, poly-ADP-ribose polymerase-1 (PARP-1) inhibitors, cisplatin, or oxaliplatin; immune checkpoint inhibitors are selected from programmed death-1 (PD-1) inhibitors, programmed death ligand 1 (PD-L1) inhibitors, anti-PD1 antibodies, anti-PD-L1 antibodies, or cytotoxic T-lymphocyte-associated protein 4 The composition according to claim 9, selected from a (CTLA4) inhibitor, an anti-CTLA4 antibody, a T cell immunoglobulin and an ITIM domain (TIGIT) inhibitor, an ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase, CD39) inhibitor, or an ecto-5'-nucleotidase (ecto-5'NTase, CD79) inhibitor.

11. The pharmaceutical composition according to claim 5, wherein the disease, disorder, or condition is cancer or an immune response-related disease, disorder, or condition.

12. The pharmaceutical composition according to claim 11, wherein the cancer is a cancer of the adrenal gland, brain, bladder, breast, bone, colon, endometrium, esophagus, head, stomach, kidney, liver, lung, mouth, muscle, neck, pancreas, prostate, retina, skin, thyroid, or leukocyte, and the immune response-related disease, disorder, or condition is selected from the group consisting of allergy, Alzheimer's disease, asthma, Crohn's disease, colitis, chronic obstructive pulmonary disease, diabetic nephropathy, glaucoma, lupus, rheumatoid arthritis, multiple sclerosis, pain, panic disorder, pancreatitis, Parkinson's disease, psoriasis, systemic sclerosis, and ulcerative colitis.

Citation Information

Patent Citations

  • CH2004

  • JP1990069496A

  • JP2003528811A